All stock reports

AEGISVOPAK evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-26T13:36:46.797022+00:00

Metrics

latest_annual_period
2026-03-31
revenue
9230782000.0
net_income
3104693000.0
operating_cash_flow
6534690000.0
free_cash_flow
-465924000.0
total_assets
84501288000.0
total_liabilities
40315908000.0
total_equity
42905706000.0
cash
4285134000.0
total_debt
37309269000.0
revenue_growth
0.48624223608150796
earnings_growth
1.4402174056185273
net_margin
0.3363412763945677
roe
0.0723608417024999
debt_to_equity
0.8695642719408929
cash_conversion
2.104778153588777
free_cash_flow_margin
-0.05047503017620825
trailing_pe
104.2537
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
7.3676
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-220bbb110195013176d42a8cc95b786463f67321f41cf8357928e5b44287b41e
Policy
stock-decisions-v1
Evidence bundle hash
65c4195ef2c79a3279a0ec35855c3ba291915d9b3e5d2738c144389828a92fc3
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 8579f9a91b48f56eb9432dd67da3dd31151ab17e4aeac87fa47b475466500204
  • daily-price: 609654db801fc5109b9f56190ea2b2b340f5e5b17c93975b35a6a61b982172a7
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was 0.57%. The trailing 20-session price return was 1.55%. The trailing 60-session price return was 5.19%. The trailing 250-session price return was 19.49%. Average cached traded value over twenty sessions was INR 582,528,697.

Risks

The closing price was -8.66% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.05047503017620825. Financial data check: balance_sheet_equation: difference=1279674000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.48624223608150796. The cached financial metric net margin is 0.3363412763945677. The cached financial metric roe is 0.0723608417024999. The cached financial metric debt to equity is 0.8695642719408929. The cached financial metric cash conversion is 2.104778153588777.

Cached observations and evidence limits